These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 9252750)
1. Characterization of the nuclear deoxyribonucleic acid content and nuclear morphometry in 71 primary cutaneous melanomas. Renard N; Goldschmidt D; Decaestecker C; Lorea P; Berthe JV; Verraes S; Ghanem G; Salmon I; Kiss R Dermatology; 1997; 194(4):318-24. PubMed ID: 9252750 [TBL] [Abstract][Full Text] [Related]
2. Primary malignant melanoma of the skin. Relationships of nuclear DNA content, nuclear morphometric variables, Clark level and tumor thickness. Talve LA; Collan YU; Ekfors TO Anal Quant Cytol Histol; 1997 Feb; 19(1):62-74. PubMed ID: 9051188 [TBL] [Abstract][Full Text] [Related]
3. Nuclear morphometry of MIB-1 positive and negative tumor cells in primary and metastatic malignant melanoma of the skin. Karbowniczek M; Chosia M; Domagała W Pol J Pathol; 1999; 50(4):235-41. PubMed ID: 10721263 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging. Pilch H; Günzel S; Schäffer U; Tanner B; Heine M Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619 [TBL] [Abstract][Full Text] [Related]
5. Is DNA ploidy of prognostic significance in stage I cutaneous melanoma? Gattuso P; Reddy V; Solans E; Kathuria S; Aranha GV; Jacobs HK; Walloch J Surgery; 1990 Oct; 108(4):702-8; discussion 708-9. PubMed ID: 2218882 [TBL] [Abstract][Full Text] [Related]
6. Nuclear morphometry, immunohistochemical staining with Ki-67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skin. Talve LA; Collan YU; Ekfors TO J Cutan Pathol; 1996 Aug; 23(4):335-43. PubMed ID: 8864921 [TBL] [Abstract][Full Text] [Related]
7. Discrimination between benign and malignant melanocytic skin lesions by multivariate analysis, quantitative S-100 immunohistochemistry, nuclear morphometry and DNA cytometry. Williams RA; Rode J; Baak JP; Charlton IG Anal Quant Cytol Histol; 1999 Aug; 21(4):353-7. PubMed ID: 10560514 [TBL] [Abstract][Full Text] [Related]
8. Influence of section thickness, mean nuclear diameter and nuclear crowding on DNA ploidy in histologic sections of melanocytic skin lesions. Williams RA; Baak JP; Meijer GA; Charlton IG Anal Quant Cytol Histol; 1999 Oct; 21(5):413-24. PubMed ID: 10560524 [TBL] [Abstract][Full Text] [Related]
9. DNA ploidy and nuclear morphometry for the classification of dysplastic nevi. Williams RA; Baak JP; Meijer GA; Charlton IG Anal Quant Cytol Histol; 1999 Oct; 21(5):437-44. PubMed ID: 10560527 [TBL] [Abstract][Full Text] [Related]
10. Flow DNA-cytometric findings of paraffin-embedded primary cutaneous melanomas related to prognosis. Lindholm C; Hofer PA; Jonsson H; Tribukait B Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 58(2):147-51. PubMed ID: 2575819 [TBL] [Abstract][Full Text] [Related]
11. Flow cytometric DNA analysis of primary cutaneous malignant melanoma. Ohnishi K; Ishikawa H Acta Derm Venereol; 1991; 71(6):525-8. PubMed ID: 1685836 [TBL] [Abstract][Full Text] [Related]
12. DNA-ploidy abnormalities are a reflection of the metastatic potential of malignant melanoma. Microfluorometric DNA analysis. Umebayashi Y; Otsuka F Acta Derm Venereol; 1997 Mar; 77(2):118-21. PubMed ID: 9111821 [TBL] [Abstract][Full Text] [Related]
13. Single cell DNA cytophotometry in clinical stage I malignant melanoma. Relationship to prognosis. Lindholm C; Hofer PA; Jonsson H Acta Oncol; 1990; 29(2):147-50. PubMed ID: 2334568 [TBL] [Abstract][Full Text] [Related]
14. P90 exceeding rate as a prognostic factor in primary malignant melanoma of the skin. A DNA image cytometric study. Talve LA; Collan YU; Ekfors TO Anal Quant Cytol Histol; 1997 Oct; 19(5):393-403. PubMed ID: 9349899 [TBL] [Abstract][Full Text] [Related]
15. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV. Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of clinicopathologic variables and DNA ploidy in stage I cutaneous malignant melanoma. Tralongo V; Daniele E; Leonardi V; Rodolico V Oncol Rep; 1998; 5(5):1095-8. PubMed ID: 9683815 [TBL] [Abstract][Full Text] [Related]
17. Stereologic estimation of volume-weighted mean nuclear volume as a predictor of prognosis in "thin" malignant melanoma. Binder M; Dolezal I; Wolff K; Pehamberger H J Invest Dermatol; 1992 Aug; 99(2):180-3. PubMed ID: 1629630 [TBL] [Abstract][Full Text] [Related]
18. Differentiating benign nevi from malignant melanoma using DNA microdensitometry and karyometry and maturation: a zonal comparison, correlation and multivariate analysis. Li LX; Crotty KA; Palmer AA; Kril JJ; Stankovic R; Scolyer RA; McCarthy SW Anal Quant Cytol Histol; 2002 Aug; 24(4):234-43. PubMed ID: 12199325 [TBL] [Abstract][Full Text] [Related]
19. Comparison of image analysis with flow cytometry for DNA content analysis in pigmented lesions of the skin. Sangueza OP; Hyder DM; White CR; Pallander J; Perkins M; Remple N; Bakke A Anal Quant Cytol Histol; 1992 Feb; 14(1):55-9. PubMed ID: 1558616 [TBL] [Abstract][Full Text] [Related]